News
Swiss Academy of Engineering Sciences SATW
mRNA 2.0: From the COVID-19 vaccine to a potential treatment for skin cancer
During the Covid-19 pandemic, mRNA technology gained worldwide recognition. Now it could also transform cancer treatment: the first personalised mRNA vaccine against melanoma has shown promising results in a large Phase III trial. When used in combination with immunotherapy, it reduced the risk of recurrence by 42 per cent. How does a vaccine work that is produced individually for each patient? And what still stands in the way of its widespread use?



